About Multicentric carpo-tarsal osteolysis with or without nephropathy
Multicentric carpo-tarsal osteolysis with or without nephropathy is a rare disease catalogued by Orphanet (ORPHA:2774). It is associated with the MAFB gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Multicentric carpo-tarsal osteolysis with or without nephropathy trials.
Search ClinicalTrials.gov for "Multicentric carpo-tarsal osteolysis with or without nephropathy" or filter by Orphanet code ORPHA:2774 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Multicentric carpo-tarsal osteolysis with or without nephropathy trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Multicentric carpo-tarsal osteolysis with or without nephropathy. Updated daily.